Treatment with Guanfacine for Hyperactive Children with Autism

Study Detail

Eligibility

  • Children 5-14 years of age with an ASD
  • Hyperactive/impulsive behaviors

Purpose

To help reduce hyperactive/impulsive behaviors in children with autism

Involvement

  • Participants will receive guanfacine or placebo (some children may also receive methylphenidate)

  • Questionnaires, interviews, psychological testing
  • Laboratory testing

Benefits

Your child may have a decrease in hyperactive/impulsive behaviors

Contact

Jenny Cowen at jcowen@mednet.ucla.edu or (310) 825-6170

Review and Approval
Renewal Date: 
2014, January 23